摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-n-butyl-2,4-dihydro-2-<4-nitro-2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one | 146949-00-0

中文名称
——
中文别名
——
英文名称
5-n-butyl-2,4-dihydro-2-<4-nitro-2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one
英文别名
5-n-butyl-2,4-dihydro-2-[4-nitro-2-(trifluoromethyl)phenyl]-3H-1,2,4-triazol-3-one;5-butyl-2-[4-nitro-2-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-one
5-n-butyl-2,4-dihydro-2-<4-nitro-2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one化学式
CAS
146949-00-0
化学式
C13H13F3N4O3
mdl
——
分子量
330.266
InChiKey
VIRQCEREFIPEOV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.49±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    90.5
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Triazolinone Biphenylsulfonamides as Angiotensin II Receptor Antagonists with High Affinity for Both the AT1 and AT2 Subtypes
    摘要:
    Angiotensin II (AII), the endogenous peptide Ligand of the AII receptor, has equivalent high affinity for both the AT(1) and AT(2) receptor subtypes while most of the reported nonpeptide AII antagonists are AT(1)-selective. In an effort to identify dual AT(1)/AT(2) nonpeptide AII antagonists, we have pursued modifications of previously prepared trisubstituted 1,2,4-triazolinone biphenylsulfonamides which exhibited subnanomolar in vitro AT(1) (rabbit aorta) AII antagonism and AT(2) (rat midbrain) IC50 values of <40 nM. Present results show that a suitable amide (or reversed amide) side chain appropriately positioned on the N-2-aryl group of these compounds gave >15-fold enhancement in AT(2) binding affinity without sacrificing nanomolar AT(1) potency (IC50). This added amide, combined with an appropriate choice of the N-substituent on the sulfonamide and the ortho substituent on the N-2-aryl group, led to an analogue (46, L-163,- 007) which exhibited subnanomolar AT(1) binding affinity and an AT(2)/AT(1) IC50 ratio of 3. This compound showed excellent iv activity at 1 mg/kg and oral efficacy at 3 mg/kg with >6 h duration in a conscious rat model. Available data suggest that the newly introduced amide side chain, mandatory for low nanomolar binding affinity at the AT(2) receptor, is well-tolerated by the AT(1) receptor and has minimal effect on the in vivo properties of these molecules.
    DOI:
    10.1021/jm00052a006
  • 作为产物:
    描述:
    2-氨基-5-硝基三氟甲苯sodium carbonate 作用下, 以 二氯甲烷 为溶剂, 以27%的产率得到5-n-butyl-2,4-dihydro-2-<4-nitro-2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one
    参考文献:
    名称:
    Substituted 1,2,4-triazoles bearing acidic functional groups as
    摘要:
    这些公式I中的新型替代三唑酮,三唑硫酮和三唑亚胺化合物可用作抗血管紧张素II拮抗剂。
    公开号:
    US05281614A1
点击查看最新优质反应信息

文献信息

  • Substituted triazolinones, triazolinethiones, and triazolinimines as
    申请人:Merck & Co., Inc.
    公开号:US05411980A1
    公开(公告)日:1995-05-02
    There are disclosed new substituted triazolinone, triazolinethione, and triazolinimine compounds which are useful as angiotensin II antagonists. These compounds have the general formula: ##STR1## wherein G is R.sup.1 or ##STR2##
    已披露了新的取代三唑酮,三唑酮和三唑亚胺化合物,这些化合物可用作血管紧张素II拮抗剂。这些化合物具有一般式:##STR1## 其中G为R.sup.1或##STR2##
  • Substituted triazolinones
    申请人:MERCK & CO. INC.
    公开号:EP0526001A1
    公开(公告)日:1993-02-03
    Substituted triazolinone compounds are angiotensin II antagonists and therefore useful in the treatment of hypertension, and related cardiovascular disorders and ocular hypertension. These compounds have the general formula:
    取代的三唑啉酮化合物是血管紧张素 II 拮抗剂,因此可用于治疗高血压、相关心血管疾病和眼压过高。这些化合物的通式如下
  • Antimigraine alkoxypyrimidine derivatives
    申请人:Bristol-Myers Squibb Company
    公开号:EP0464558B1
    公开(公告)日:1994-12-28
  • ACIDIC ARALKYL TRIAZOLE DERIVATIVES ACTIVE AS ANGIOTENSIN II ANTAGONISTS
    申请人:MERCK & CO. INC.
    公开号:EP0586513A1
    公开(公告)日:1994-03-16
  • US5281614A
    申请人:——
    公开号:US5281614A
    公开(公告)日:1994-01-25
查看更多